|本期目录/Table of Contents|

[1]易 憬,熊 飞,苏良平,等.腺性膀胱炎动物模型不同治疗方法的效果分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(06):514-516.
　YI Jing,XIONG Fei,SU Liang-ping,et al.Analysis on the effect of treatments for the glandular cystitis animal models[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(06):514-516.
点击复制

腺性膀胱炎动物模型不同治疗方法的效果分析()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第14卷
期数:
2012年06期
页码:
514-516
栏目:
出版日期:
2012-11-20

文章信息/Info

Title:
Analysis on the effect of treatments for the glandular cystitis animal models
文章编号:
1672-271X(2012)06-0514-03
作者:
易 憬1; 熊 飞2; 苏良平1; 陈 登1; 杨 兵1; 张盛龙1; 张宝珍1; 刘 长1; 易文龙3
1.435006 湖北黄石，武汉钢铁(集团)公司大冶铁矿职工医院;2.430030 湖北武汉，华中科技大学同济医学院计划生育研究所;3.430064 湖北武汉，武汉科技大学附属天佑医院
Author(s):
YI Jing1; XIONG Fei2; SU Liang-ping1; CHEN Deng1; YANG Bing1; ZHANG Sheng-long1; ZHANG Bao-zhen1; LIU Chang1; YI Wen-long3.
1.Daye Iron Mine Staff Hospital,Wuhan Iron and Steel (Group) Corporation,Huangshi,Hubei 435006,China；2.Institute of Family Planning Research,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430030,China；3.Tianyou Hospital affiliated to Wuhan University of Science and Technology,Wuhan,Hubei 430064,China
关键词:
腺性膀胱炎; 托特罗定; 排尿压; 最大膀胱容量
Keywords:
glandular cystitis;  tolterodine;  voiding pressure;  maximum bladder capacity
分类号:
R694.3
DOI:
-
文献标志码:
A
摘要:
目的 探讨腺性膀胱炎的最佳治疗方法。方法 40只成年雌性健康SD大鼠，其中35只建成腺性膀胱炎动物模型，随机分为生理盐水对照组5只(A组)、抗感染组10只(B组)、托特罗定组10只(C组)、抗感染+托特罗定组10只(D组)进行研究，在治疗前和开始治疗后两周均给予尿动力学检查。另外5只不做任何处理，作正常对照组(E组)，在和动物模型相同的时间点给予两次尿动力学检查。结果 正常对照组与治疗后的生理盐水对照组、抗感染组、托特罗定组的排尿压和最大膀胱容量有显著性差异(P<0.05)，正常对照组与治疗后抗感染+托特罗定组的排尿压和最大膀胱容量无显著性差异(P>0.05)，治疗后的生理盐水对照组与抗感染组、托特罗定组的排尿压和最大膀胱容量有显著性差异(P<0.05)，治疗后的抗感染组、托特罗定组与抗感染+托特罗定组的排尿压和最大膀胱容量有显著性差异(P<0.05)。结论 抗感染与托特罗定共同治疗腺性膀胱炎动物模型，有较好的效果。
Abstract:
Objective To explore the better treatment for glandular cystitis.Methods 40 adult female SD rats were divided into 5 groups randomly (5 in physiological saline control group,10 in anti-infection treatment group,10 in tolterodine treatment group,10 in anti-infection combined with tolterodine treatment group,other 5 in normal control group without any treatment).The urodynamic parameters were evaluated before the treatment and two weeks after the treatment.Results After two weeks treatment,there were significant difference in the voiding pressure and maximum bladder capacity among normal control group,physiological saline control group,anti-infection treatment group,and tolterodine treatment group (P<0.05).There is no significant difference in the voiding pressure and maximum bladder capacity between normal control group and anti-infection combined with tolterodine treatment group post-treated (P>0.05).There was significant difference in the voiding pressure and maximum bladder capacity between physiological saline control group and anti-infection treatment group,tolterodine treatment group post-treated (P<0.05).There were significant difference in the voiding pressure and maximum bladder capacity amonganti-infection combined with tolterodine treatment group,anti-infection treatment group and tolterodine treatment group(P<0.05).Conclusion Antibiotics combined with tolterodine can effectively improve urodynamic parameters of cystitis glandularis animal models.

参考文献/References:

[1]Pantanowitz L,Otis CN. Cystitis glandularis[J].Diagn Cytopathol，2008,36(3):181-182.
[2]Jankovic Velickovic L,Katic V,Hattori T,et al.Differences in the expression of mucins in various forms of cystitis glandularis[J].Pathol Res Pract，2007，203(9):653-658.
[3]于泓远，刘贤奎，孔垂泽.腺性膀胱炎的诊断和治疗(附40例报告)[J].中国现代医学杂志，2010,20(2):464-466.
[4]易 憬，熊 飞，苏良平，等.SD大鼠腺性膀胱炎动物模型的建立[J].临床外科杂志，2008,16(8):553-554.
[5]易 憬，熊 飞，苏良平，等.腺性膀胱炎动物模型的尿流动力学检查[J].临床泌尿外科杂志，2008,23(11):865-867.
[6]Srivastava S,Yan B,Chin SY,et al.Nuclear p53 expression is associated with allelic imbalance (TP53) in glandular dysplasia and typical cystitis glandularis:a LCM-based molecular analysis[J].Clin Genitourin Cancer，2012，10(1):57-59.
[7]Zozumi M,Nakai M,Matsuda I,et al.Primary carcinoid tumor of the urinary bladder with prominent subnuclear eosinophilic granules[J].Pathol Res Pract，2012，208(2):109-112.
[8]宋岩峰,李亚钦,何晓宇.军人家属及部分女兵下尿路症状调查分析和防治[J].东南国防医药,2004,6(2):92-94.
[9]仇永亮,郭春晓,程 文.托特罗定缓释片治疗膀胱过度活动症的临床研究[J].东南国防医药,2010,12(6):487-489.
[10]Behzatolu K.Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder[J].Ann Diagn Pathol，2011，15(6):422-426.
[11]易 憬，熊 飞，苏良平，等.大鼠腺性膀胱炎的病因学研究[J].华中科技大学学报:医学版，2008，37(4):547-549.
[12]陈志强,马胜利,吴天鹏,等.腺性膀胱炎专题讨论[J].临床泌尿外科杂志,2003,18(1):60-62.
[13]曾 伟,陈志强,叶章群.下尿路感染与腺性膀胱炎关系的临床研究[J] .临床泌尿外科杂志,2004,19(6):350-351.
[14]Williamson SR,Lopez-Beltran A,Montironi R,et al.Glandular lesions of the urinary bladder:clinical significance and differential diagnosis[J].Histopathology，2011，58(6):811-834.
[15]汤 昊,孙颖浩.腺性膀胱炎及其诊治[J].临床泌尿外科杂志.2008,23(9):715-718.
[16]Lim M,Adsay NV,Grignon D,et al.Urothelial carcinoma with villoglandular differentiation:a study of 14 cases[J].Mod Pathol，2009，22(10):1280-1286.
[17]张晓光,徐 勇,杨 阔.腺性膀胱炎的诊断与治疗(附64 例报告)[J].天津医科大学学报，2008,14(2):200-202.
[18]陈 敏，肖传国，曾甫清，等.腺性膀胱炎尿动力学检查及其临床意义[J].临床泌尿外科杂志，2003,18(6):344-346.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2012-11-20